These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24963758)

  • 1. Severity of birth defects after propylthiouracil exposure in early pregnancy.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    Thyroid; 2014 Oct; 24(10):1533-40. PubMed ID: 24963758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
    Morales DR; Fonkwen L; Nordeng HME
    Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.
    Andersen SL; Lönn S; Vestergaard P; Törring O
    Eur J Endocrinol; 2017 Oct; 177(4):369-378. PubMed ID: 28780518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithyroid Drug Side Effects in the Population and in Pregnancy.
    Andersen SL; Olsen J; Laurberg P
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1606-14. PubMed ID: 26815881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithyroid Drug Use in Pregnancy and Birth Defects: Why Some Studies Find Clear Associations, and Some Studies Report None.
    Laurberg P; Andersen SL
    Thyroid; 2015 Nov; 25(11):1185-90. PubMed ID: 26359310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of antithyroid drugs should be reduced as much as possible in the first trimester].
    Andersen SL; Laurberg P
    Ugeskr Laeger; 2014 Sep; 176(39):. PubMed ID: 25294327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
    Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
    [No Abstract]   [Full Text] [Related]  

  • 13. Teratogen update: Antithyroid medications.
    Romeo AN; Običan SG
    Birth Defects Res; 2020 Sep; 112(15):1150-1170. PubMed ID: 32738035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.
    Li H; Zheng J; Luo J; Zeng R; Feng N; Zhu N; Feng Q
    PLoS One; 2015; 10(5):e0126610. PubMed ID: 25974033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
    Li X; Liu GY; Ma JL; Zhou L
    Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
    Liu Y; Li Q; Xu Y; Chen Y; Men Y
    PLoS One; 2023; 18(5):e0286097. PubMed ID: 37205692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero.
    Löllgen RM; Calza AM; Schwitzgebel VM; Pfister RE
    J Pediatr Endocrinol Metab; 2011; 24(3-4):215-8. PubMed ID: 21648296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study.
    Rosenfeld H; Ornoy A; Shechtman S; Diav-Citrin O
    Br J Clin Pharmacol; 2009 Oct; 68(4):609-17. PubMed ID: 19843064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
    Laurberg P; Andersen SL
    Eur J Endocrinol; 2014 Jul; 171(1):R13-20. PubMed ID: 24662319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.